TV

Travere Therapeutics, Inc.$TVTXHot on

Biotechnology

$62.76-3.06%

1Y+159.4%

56 posts1.4×

Bullish sentiment

Travere Therapeutics posters cheer strong FILSPARI launch — US net product sales +96% YoY to $141M, 2,012 new PSFs received in Q2, and pegtibatinase HARMONY Phase 3 enrollment ongoing with 2H27 topline. JPMorgan upgrade with $90 PT and continued analyst PT raises heading into August. In-licensing of civorebrutinib expands the pipeline. Sentiment is decisively bullish.

Proven numbers

Travere Therapeutics is a rare-disease biotech commercializing FILSPARI (IgA nephropathy) and developing pegtibatinase for homocystinuria — a genuine commercial-launch story, and the tape has responded with a 159% T12M move. • Revenue grew 55.6% YoY last quarter to $127M with 94% gross margin — the four-quarter run of 56-162% growth confirms the FILSPARI launch is genuinely accelerating (2,012 new PSFs in Q2, US net product sales +96% YoY to $141M), and the last four EPS surprises came in wide (-175% to +190%). • JPMorgan upgraded with a $90 PT, and pegtibatinase HARMONY Phase 3 enrollment ongoing with 2H27 topline plus the in-licensing of civorebrutinib expands the pipeline — that's real catalyst path visibility. • CEO Dube printed $4.6M in insider sales on 9/17 plus officer Heerma combined ~$11M in M-Exempt-plus-S-Sale activity the same day — that's a ~$15M+ insider-selling cluster in a single day into the 87th percentile of range on 1.64x-average volume, which is the friction bulls should notice. Oct 29 Q3 earnings — another 50%+ revenue print with clean FILSPARI new-PSF growth commentary extends the trade toward the JPM $90 target; a soft PSF-conversion print or a fresh insider-selling cluster is the invalidator on a name where the fundamentals are real but the CEO-plus-officer distribution is unusually heavy.

EN

Entegris, Inc.$ENTGHot on

Semiconductors

$142.25+5.63%

1Y+48.2%

67 posts1.3×

Bullish sentiment

Entegris posters cheer a Q2 breakout — net sales $883.2M vs $835M est (+11% YoY), adj EPS $0.93 vs $0.82 (+41% YoY), Q3 guide $905-935M vs $878M consensus, and a powerful capex-rebound catalyst driving Advanced Purity Solutions. Rep. Delaney's 11 buys since March add insider-signal narrative. Sentiment is decisively bullish on the AI-semi supercycle broadening.

Proven numbers

Entegris is a leading provider of specialty chemicals, materials, and delivery systems for semiconductor manufacturing — a real quality compounder in the semi-tools stack, and Q2 delivered exactly the AI-supercycle-broadening bulls needed. • Revenue grew 5% YoY last quarter to $811.9M — but the reported print at $883.2M vs $835M estimate (+11% YoY) plus adj EPS $0.93 vs $0.82 estimate (+41% YoY) shows the real cycle recovery is landing, and the four-quarter EPS beat cadence of 0-15% consistently confirms the sell-side under-modeled the ramp. • Q3 guide at $905-935M vs $878M consensus is a powerful raise, and the capex-rebound catalyst driving Advanced Purity Solutions is the specific segment attribution — Rep Delaney's 11 buys since March add a rare congressional insider-signal narrative. • Volume 1.55x-average with the stock at 62nd-percentile-of-range — genuine institutional accumulation into the setup, and the recent Executive Chair transition (Bertrand Loy retiring July 31) is background governance activity worth naming. Oct 29 Q3 earnings — another double-digit revenue print with clean Advanced Purity Solutions commentary and any FY27 guide extends the trade toward all-time highs; a soft semi-capex signal or a competitive commentary from a peer is the invalidator at 103x trailing earnings on 62nd-percentile-of-range.

DH

Danaher Corporation$DHRHot on

Medical - Diagnostics & Research

$211.77-0.34%

1Y+8.4%

74 posts1.4×

Bullish sentiment

Danaher posters cheer the CEO change (Julie in, 'Eeyore' out) as a +2% AH reaction, with DHR appearing on liquid-leader watchlists and technical accumulation setups. Some Rales-family equity-grant frustration. Sentiment is broadly bullish on the leadership refresh.

Proven numbers

Danaher is +10% TTM at $212.45, at the 63rd percentile of its 52-week range with three of the last four EPS beats — Q2 EPS $1.94 topped by 4.9% on $6.27B revenue. TTM P/E 35.4x, 21% op margin, 61% gross margin. • Board appointed Julie Sawyer Montgomery President and CEO effective 1 Oct per 3 Aug 8-K — planned succession • Outgoing CEO Rainer Blair sold 58,255 shares at $218.63 for $12.74M on 21 Aug — pre-handover distribution • Declared regular quarterly dividend 15 Sep; BofA made a new investment per 15 Sep 13F headline; 30-day volume ran 1.9x normal Q3 earnings on 20 Oct is the near-term test; Cepheid diagnostics volumes, Beckman Coulter/Cytiva margin trajectory, and any incoming-CEO commentary drive the reaction.

HC

Warrior Met Coal, Inc.$HCCHot on

Coal

$87.93-4.22%

1Y+37.8%

39 posts1.4×

Bullish sentiment

Bullish and quiet, with users celebrating new highs this week and citing Mohnish Pabrai's estimated $57 cost basis implying a roughly 19% normalized free-cash-flow yield, a level at which "both companies could theoretically retire their entire market cap through buybacks alone in under seven years." One post flags a caveat, noting that on August 19 the CEO and two insiders sold about $6.1M worth at prices near $105.

CT

Cognizant Technology Solutions Corporation$CTSHHot on

Information Technology Services

$59.87-3.25%

1Y-14.8%

88 posts1.4×

Bullish sentiment

X users are cautiously bullish on Cognizant after the stock filled its April 2026 gap, which posters read as a constructive technical setup. Commentary focuses on the chart rather than fundamentals, with several accounts flagging the fill as a base-building moment. Volume is thin but directionally positive.

CA

Caris Life Sciences, Inc.$CAIHot on

Biotechnology

$29.98-3.04%

1Y-10.3%

73 posts1.4×

Bullish sentiment

Caris Life Sciences chatter is thin but positive. Traders cite the Krypton Research team +51% closed and +40% ongoing thesis (diagnostics too cheap and biggest AI beneficiaries), inclusion in Accelerating Earnings and Biotechnology bullish-scan screens, and diagnostics 'playing out' with CAI/WGS/XGN. A cautionary note that BTC beat most of these over 5 years. Overall bullish.

PA

Paycom Software, Inc.$PAYCHot on

Software - Application

$226.28+0.10%

1Y+4.5%

22 posts

Bullish sentiment

Paycom rallies 25-40% YTD after strong results with founder Chad Richison aggressively buying back cheap shares (frames as identifying opportunity), delivering AI-related capex returns. Users celebrate multi-thousand-dollar wins on PAYC LEAPS calls (+$14K, +$48K), calling it nearly doubled since the SaaSpocalypse lows earlier in the year and fighting the jobs+AI debate nicely.

MT

MasTec, Inc.$MTZHot on

Engineering & Construction

$214.38+3.19%

1Y+7.5%

56 posts1.3×

Bullish sentiment

MasTec is part of the E&C construction basket up 76% YTD, fueled by $725B in combined hyperscaler AI infrastructure capex commitments; alongside STRL and AGX, it is framed as a core 'builder of the AI boom' printing money in the infrastructure supercycle.

CS

Carlisle Companies Incorporated$CSLHot on

Construction Materials

$314.7-1.77%

1Y-5.1%

11 posts

Bullish sentiment

CSL is up 75% from lows in under 3 months, with RBC noting the FY26 beat and 2H strength in the core Ig business — 'the worst is now behind them.' Bulls report daily +5% pops in ATH FOMO, targets to $200 on the current pace, and pair CSL with COH as beaten-down blue chips popping on outlook. Skeptical voices frame the move as macro/positioning flow rather than fundamental inflection, but the tone across the sample is confidently bullish.

MK

MKS Inc.$MKSIHot on

Hardware, Equipment & Parts

$252.08+4.93%

1Y+94.0%

34 posts1.5×

PendingInsufficient posts on X for reliable sentiment analysis.

LY

LyondellBasell Industries N.V.$LYBHot on

Chemicals - Specialty

$61.91-3.64%

1Y+17.5%

100 posts1.4×

Bullish sentiment

LyondellBasell sentiment is confidently bullish. Users celebrate LYB as one of the chemical-40W-cycle-low leaders (with CE), 'been wanting to own LYB — today's the day long under $62', LYB putting some shares 'into let it ride' price over all major MAs, and LYB among the bidders for Shell's US chemicals business valued up to $8B (with XOM/APO/Kuwait Petroleum). One bull sold a slice of trade shares for ~10% profit and stock went ex-div today $0.69. Skepticism is essentially absent from the sample; the modal stance is 'chemicals cycle low + M&A optionality + let-it-ride'.

FI

Five9, Inc.$FIVNHot on

Software - Application

$32.47-5.88%

1Y+22.2%

50 posts1.3×

Bullish sentiment

Five9 chatter is uniformly bullish, describing a coiling earnings candle over a rising 2-day, firmly above the 21-day, and clean levels to trade against. Traders note a potential resistance level from two years ago that could cap the initial move. Overall tone is constructive with tempered targets.

PS

Everpure, Inc$PSTGHot on

Computer Hardware

$86.22+9.14%

1Y+61.9%

19 posts

PendingInsufficient posts on X for reliable sentiment analysis.

MC

Microchip Technology Incorporated$MCHPHot on

Semiconductors

$73.27+3.46%

1Y+10.6%

132 posts1.4×

Bullish sentiment

Chatter is small but pointedly bullish, driven by an eye-popping options print. A single diagonal (sell 150,110 October $72.50 calls, buy 119,030 December $65 calls) accounts for most of the day's 272,935-contract volume and a 135:1 call/put ratio. Fundamental voices cite a PEG of 0.42, edge-AI and data-center demand, and the Hailo acquisition; a chartist flags the "trendline support on the weekly timeframe" with an ARM-style setup comparison.

IE

IES Holdings, Inc.$IESCHot on

Engineering & Construction

$322.16+1.58%

1Y+70.7%

37 posts1.4×

Bullish sentiment

IES Holdings delivered a monster Q3 — revenue $1.24B beat $1.08B est (+40% YoY), adj EPS $6.70 vs $4.83 est. 2-for-1 stock split approved. Stock +33% post-earnings. Bulls note IESC 'is a $15B EV company that doesn't do earnings calls' and 'essentially no analyst coverage.' Top stock recommendation 6 months running from one holder. Grouped with EME +20%, PWR +21%, FIX in data-center infrastructure names not-APLD. Tone: high-conviction under-covered data-center-power structural bull.

AS

Asana, Inc.$ASANHot on

Software - Application

$9.51-5.70%

1Y-33.8%

89 posts1.4×

Bullish sentiment

Asana is bullish on X — RBC raised PT to $9.50 (from $8), Piper raised to $9 (from $7), first double-digit US revenue growth in 2 years with enterprise/upmarket business showing conviction. CEO on model-routing becoming a margin lever adds AI-margin thesis; testing 200DMA to the penny.

ZM

Zoom Communications, Inc.$ZMHot on

Software - Application

$88.77-3.68%

1Y+2.2%

142 posts1.3×

Bullish sentiment

Zoom appoints former Oracle CFO Jeff Epstein to its board effective immediately, and the tape adds roughly $671M of market cap in the session as the news dominates the feed, with jokes about the name aside the reaction is squarely positive.

FI

Comfort Systems USA, Inc.$FIXHot on

Engineering & Construction

$1,651.37+4.92%

1Y+106.6%

86 posts1.3×

Bullish sentiment

Comfort Systems USA chatter is quietly bullish. Goldman Sachs highlights FIX as the cleanest Texas and EM data-center construction beneficiary with Texas already generating 42% of YTD organic growth, calling US datacenter construction reaccelerating. Retail holders describe adding shares in Roth IRAs and framing FIX as an all-American MEP boring compounder. Tone is patient quality-industrial positioning with a specific AI-adjacent tailwind.

RS

Rush Street Interactive, Inc.$RSIHot on

Gambling, Resorts & Casinos

$23.30-7.72%

1Y+7.4%

52 posts1.5×

Bullish sentiment

Rush Street Interactive is on multiple unusual-option and unusual-call-volume scans this week, and 'bull flow continues to be persistent' — even after Elite members received a bearish signal on July 28 that hit for -14.6% over 30 days. Setup has flipped back to positive flow accumulation.

LS

Lattice Semiconductor Corporation$LSCCHot on

Semiconductors

$110.96+2.24%

1Y+54.9%

18 posts

Bullish sentiment

Lattice Semiconductor posters celebrate a Q2 blowout — revenue $201.1M vs $185M est (+62% YoY), adj EPS $0.53 vs $0.44 est (+120% YoY), and the AMI acquisition pulling the $1B annual run-rate target forward a full quarter to Q3 2026. Q3 guide of $245-265M revenue crushes the $197M consensus, with AMI adding 40% EBITDA margins and >75% gross margins. Sentiment is uniformly bullish on the FPGA-AI story.

Stocks trending on X this week

Stocks trending on X right now